Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Health centers, rare-disease advocates urge state action on 340B restrictions and contract pharmacy limits
Summary
Representatives of Michigan's federally qualified health centers and rare-disease advocates urged the House Health Policy Committee on Tuesday to address manufacturer-imposed limits and contract-pharmacy restrictions on the federal 340B drug-pricing program, saying the limits reduce revenue that funds nonreimbursable services.
Representatives of Michigan's federally qualified health centers, hospitals' community clinics and rare-disease advocates urged the House Health Policy Committee on Tuesday to address manufacturer-imposed limits and contract-pharmacy restrictions on the federal 340B drug-pricing program, saying the limits reduce revenue that health centers use to provide nonreimbursable services.
Frank Waters of the Michigan Primary Care Association told the committee that Michigan has 41 health centers with about 400 locations serving close to 700,000 residents and that centers use 340B savings to support services such as transportation, dental care, behavioral health and discounted prescriptions.
Michael (Mike) Wieses, CEO of Hackley Community Care in Muskegon, said 340B savings helped offset operating losses: he reported a combined medical and dental…
Already have an account? Log in
Subscribe to keep reading
Unlock the rest of this article — and every article on Citizen Portal.
- Unlimited articles
- AI-powered breakdowns of topics, speakers, decisions, and budgets
- Instant alerts when your location has a new meeting
- Follow topics and more locations
- 1,000 AI Insights / month, plus AI Chat
